← Eichor
Condition: Seasonal Allergic Rhinitis Sar Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Seasonal Allergic Rhinitis Sar

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Phase 3 · 1 location(s) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · NCT07154342A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Und
Phase 2 · 1 location(s) · Alixer Nexgen Therapeutics Limited · NCT07219849
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.